BOTZ vs XLV
Global X Robotics & Artificial Intelligence ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.68% for BOTZ.
- • XLV pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | BOTZ | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.68% | 0.08% |
Dividend yield Trailing 12-month yield. | 0.62% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $3.44B | $37.88B |
YTD return | 10.07% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.71 | 0.58 |
P/E ratio | 39.66 | 26.68 |
Last price | $39.83 | $144.72 |
Inception | — | — |
Issuer | Global X | State Street |
BOTZ top holdings
| ABBN.SW | ABB Ltd | 8.88% |
| 6861.T | Keyence Corp | 8.82% |
| 6954.T | Fanuc Corp | 8.34% |
| NVDA | NVIDIA Corp | 8.21% |
| ISRG | Intuitive Surgical Inc | 6.95% |
| 6273.T | SMC Corp | 4.71% |
| 300124.SZ | Shenzhen Inovance Technology Co Ltd Class A | 4.16% |
| 6383.T | Daifuku Co Ltd | 3.48% |
| 9660.HK | Horizon Robotics Class B | 2.45% |
| GOOGL | Alphabet Inc Class A | 2.41% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About BOTZ
BOTZ (Global X Robotics & Artificial Intelligence ETF) is Robotics, automation, and AI companies globally. Managed by Global X, the fund carries $3.4B in assets under management, an expense ratio of 0.68%, a dividend yield of 0.62%. Its largest holding is ABB Ltd (ABBN.SW), which represents 8.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.1%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.